Abstract
Background: Hemiplegia is a common symptom after acute cerebral infarction.
Objective: This study aimed to explore the influence factors of gait performance and investigate whether donepezil could improve gait performance in patients with an acute cerebral infarction.
Methods: A total of 107 patients who experienced unilateral paresis after an acute cerebral infarction incident were enrolled in this prospectively observational study. Participants underwent a 3- month assessment. At the study's conclusion, patients were divided into 2 groups-those who received donepezil daily (observation Group) and those who did not (Control Group).
Results: There was a significant difference (t=3.269, P=0.001) of Wisconsin Gait Scale (WGS) score between single site infarction (27.11±6.65) and multiple sites infarction (31.54±6.42). For gender, smoking, drinking, hypertension, hyperlipidemia and diabetes, there was no difference in WGS scores between subgroups (P>0.05), respectively. The patient's admission National Institute of Health Stroke Scale(NIHSS) score had a strongly positive correlation with WGS score (r=0.850, P<0.001). Besides, age (r=0.218, P=0.024), glycosylated hemoglobin (r=0.274, P=0.004), MMSE (r=-0.261, P=0.007) and Montreal Cognitive Assessment (MoCA) (r=-0.272, P=0.005) had a weak correlation with WGS scores. Multivariate analysis showed age (95% CI: 0.042~0.188, P=0.002), admission NIHSS score (95% CI: 2.405~3.137, P<0.001) and multiple sites infarction (95% CI: 0.044~2.983, P=0.044) were independent risk factors of WGS scores. WGS scores of both observation and control groups gradually decreased after admission (P<0.001). At 3 months after admission, WGS score of the observation group was significantly lower than the control group (t=2.468, P=0.015). There were no significant differences between observation and control group at admission and 1 month after admission (P>0.05) and WGS scores of both single site and multiple sites infarction gradually decreased at one month and three months after admission (P<0.001), while there was no significant difference between two groups (P>0.05).
Conclusion: Admission NIHSS score, age and multiple sites infarction were independent risk factors of WGS score. Donepezil could improve gait performance in patients with acute cerebral infarction.
Keywords: Donepezil, cerebral infarction, gait performance, WGS, risk factors, NIHSS.
[http://dx.doi.org/10.1159/000441085] [PMID: 26505981]
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.06.014]
[http://dx.doi.org/10.1212/WNL.0000000000000186] [PMID: 24489132]
[http://dx.doi.org/10.1016/j.bbadis.2016.01.015] [PMID: 26806700]
[http://dx.doi.org/10.1111/ene.12743] [PMID: 26040251]
[http://dx.doi.org/10.3109/09638288.2014.911969] [PMID: 24754638]
[http://dx.doi.org/10.1161/STROKEAHA.114.007346] [PMID: 25677599]
[http://dx.doi.org/10.1016/j.gaitpost.2018.12.036] [PMID: 30599331]
[http://dx.doi.org/10.1016/j.pjnns.2016.11.004] [PMID: 27916248]
[http://dx.doi.org/10.1097/MD.0000000000004360] [PMID: 27495041]
[http://dx.doi.org/10.1016/S1836-9553(13)70183-8] [PMID: 23896334]
[http://dx.doi.org/10.1007/s00401-018-1859-2] [PMID: 29752550]
[PMID: 27117369]
[http://dx.doi.org/10.1016/j.jdiacomp.2018.02.006] [PMID: 29793824]
[http://dx.doi.org/10.1161/STROKEAHA.117.019081] [PMID: 29051218]
[http://dx.doi.org/10.1177/1747493016676619]
[http://dx.doi.org/10.1016/j.jns.2018.03.022] [PMID: 29627022]
[http://dx.doi.org/10.1159/000331924] [PMID: 22104640]
[http://dx.doi.org/10.1001/jama.2019.9346] [PMID: 31334795]
[http://dx.doi.org/10.1016/j.mehy.2017.08.017] [PMID: 28915969]
[http://dx.doi.org/10.1111/ene.13872] [PMID: 30565793]
[http://dx.doi.org/10.1161/01.STR.0000190839.29234.50] [PMID: 16282540]
[PMID: 26629841]